Efficacy of Solifenacin on Irritable Bowel Syndrome With Diarrhea: Open-label Prospective Pilot Trial

BACKGROUND/AIMS: Solifenacin, a muscarinic type 3 receptor antagonist, is used to treat overactive bladder in adults. The aim of this study is to examine the efficacy of solifenacin on the symptomatic relief of diarrhea predominant irritable bowel syndrome (IBS-D). METHODS: A total of 20 patients wi...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Fukushima, Yasushi, Suzuki, Hidekazu, Matsuzaki, Juntaro, Kiyosue, Arihiro, Hibi, Toshifumi
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Korean Society of Neurogastroenterology and Motility 2012
Aiheet:
Original Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC3400820/
https://ncbi.nlm.nih.gov/pubmed/22837880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5056/jnm.2012.18.3.317
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia